nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimercaprol—Salivation—Irinotecan—pancreatic cancer	0.0477	0.0477	CcSEcCtD
Dimercaprol—Lacrimation—Irinotecan—pancreatic cancer	0.0315	0.0315	CcSEcCtD
Dimercaprol—Lacrimation—Fluorouracil—pancreatic cancer	0.0302	0.0302	CcSEcCtD
Dimercaprol—Abscess—Sunitinib—pancreatic cancer	0.0284	0.0284	CcSEcCtD
Dimercaprol—Lacrimation increased—Sunitinib—pancreatic cancer	0.0244	0.0244	CcSEcCtD
Dimercaprol—Blood pressure increased—Sunitinib—pancreatic cancer	0.0225	0.0225	CcSEcCtD
Dimercaprol—Tingling sensation—Fluorouracil—pancreatic cancer	0.0221	0.0221	CcSEcCtD
Dimercaprol—Lacrimation—Docetaxel—pancreatic cancer	0.0218	0.0218	CcSEcCtD
Dimercaprol—Lacrimation increased—Irinotecan—pancreatic cancer	0.0201	0.0201	CcSEcCtD
Dimercaprol—Lacrimation increased—Fluorouracil—pancreatic cancer	0.0192	0.0192	CcSEcCtD
Dimercaprol—Burning sensation—Docetaxel—pancreatic cancer	0.0184	0.0184	CcSEcCtD
Dimercaprol—Salivary hypersecretion—Irinotecan—pancreatic cancer	0.018	0.018	CcSEcCtD
Dimercaprol—Rhinorrhoea—Docetaxel—pancreatic cancer	0.0158	0.0158	CcSEcCtD
Dimercaprol—Lacrimation—Epirubicin—pancreatic cancer	0.0147	0.0147	CcSEcCtD
Dimercaprol—Nasopharyngitis—Sunitinib—pancreatic cancer	0.0146	0.0146	CcSEcCtD
Dimercaprol—Conjunctivitis—Erlotinib—pancreatic cancer	0.0141	0.0141	CcSEcCtD
Dimercaprol—Sweating—Tamoxifen—pancreatic cancer	0.0141	0.0141	CcSEcCtD
Dimercaprol—Lacrimation increased—Docetaxel—pancreatic cancer	0.0139	0.0139	CcSEcCtD
Dimercaprol—Lacrimation—Doxorubicin—pancreatic cancer	0.0136	0.0136	CcSEcCtD
Dimercaprol—Blood pressure increased—Docetaxel—pancreatic cancer	0.0128	0.0128	CcSEcCtD
Dimercaprol—Burning sensation—Epirubicin—pancreatic cancer	0.0124	0.0124	CcSEcCtD
Dimercaprol—Nasopharyngitis—Fluorouracil—pancreatic cancer	0.0115	0.0115	CcSEcCtD
Dimercaprol—Burning sensation—Doxorubicin—pancreatic cancer	0.0115	0.0115	CcSEcCtD
Dimercaprol—Muscle spasms—Tamoxifen—pancreatic cancer	0.011	0.011	CcSEcCtD
Dimercaprol—Abscess—Epirubicin—pancreatic cancer	0.0109	0.0109	CcSEcCtD
Dimercaprol—Abscess—Doxorubicin—pancreatic cancer	0.0101	0.0101	CcSEcCtD
Dimercaprol—Sweating—Irinotecan—pancreatic cancer	0.00993	0.00993	CcSEcCtD
Dimercaprol—Anxiety—Tamoxifen—pancreatic cancer	0.00973	0.00973	CcSEcCtD
Dimercaprol—Sweating—Gemcitabine—pancreatic cancer	0.00967	0.00967	CcSEcCtD
Dimercaprol—Conjunctivitis—Fluorouracil—pancreatic cancer	0.00964	0.00964	CcSEcCtD
Dimercaprol—Anxiety—Erlotinib—pancreatic cancer	0.00963	0.00963	CcSEcCtD
Dimercaprol—Muscle spasms—Sunitinib—pancreatic cancer	0.00944	0.00944	CcSEcCtD
Dimercaprol—Lacrimation increased—Epirubicin—pancreatic cancer	0.00937	0.00937	CcSEcCtD
Dimercaprol—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00905	0.00905	CcSEcCtD
Dimercaprol—Lacrimation increased—Doxorubicin—pancreatic cancer	0.00867	0.00867	CcSEcCtD
Dimercaprol—Paraesthesia—Tamoxifen—pancreatic cancer	0.00841	0.00841	CcSEcCtD
Dimercaprol—Salivary hypersecretion—Epirubicin—pancreatic cancer	0.00838	0.00838	CcSEcCtD
Dimercaprol—Nasopharyngitis—Docetaxel—pancreatic cancer	0.00831	0.00831	CcSEcCtD
Dimercaprol—Pain—Tamoxifen—pancreatic cancer	0.008	0.008	CcSEcCtD
Dimercaprol—Pain—Erlotinib—pancreatic cancer	0.00792	0.00792	CcSEcCtD
Dimercaprol—Muscle spasms—Irinotecan—pancreatic cancer	0.00778	0.00778	CcSEcCtD
Dimercaprol—Salivary hypersecretion—Doxorubicin—pancreatic cancer	0.00776	0.00776	CcSEcCtD
Dimercaprol—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00765	0.00765	CcSEcCtD
Dimercaprol—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00757	0.00757	CcSEcCtD
Dimercaprol—Abdominal pain—Tamoxifen—pancreatic cancer	0.0074	0.0074	CcSEcCtD
Dimercaprol—Abdominal pain—Erlotinib—pancreatic cancer	0.00732	0.00732	CcSEcCtD
Dimercaprol—Paraesthesia—Sunitinib—pancreatic cancer	0.0072	0.0072	CcSEcCtD
Dimercaprol—Conjunctivitis—Docetaxel—pancreatic cancer	0.00696	0.00696	CcSEcCtD
Dimercaprol—Pain—Sunitinib—pancreatic cancer	0.00686	0.00686	CcSEcCtD
Dimercaprol—Asthenia—Tamoxifen—pancreatic cancer	0.00672	0.00672	CcSEcCtD
Dimercaprol—Asthenia—Erlotinib—pancreatic cancer	0.00664	0.00664	CcSEcCtD
Dimercaprol—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00656	0.00656	CcSEcCtD
Dimercaprol—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00638	0.00638	CcSEcCtD
Dimercaprol—Abdominal pain—Sunitinib—pancreatic cancer	0.00634	0.00634	CcSEcCtD
Dimercaprol—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00622	0.00622	CcSEcCtD
Dimercaprol—Tachycardia—Fluorouracil—pancreatic cancer	0.00617	0.00617	CcSEcCtD
Dimercaprol—Vomiting—Tamoxifen—pancreatic cancer	0.00595	0.00595	CcSEcCtD
Dimercaprol—Paraesthesia—Irinotecan—pancreatic cancer	0.00593	0.00593	CcSEcCtD
Dimercaprol—Vomiting—Erlotinib—pancreatic cancer	0.00589	0.00589	CcSEcCtD
Dimercaprol—Headache—Tamoxifen—pancreatic cancer	0.00586	0.00586	CcSEcCtD
Dimercaprol—Headache—Erlotinib—pancreatic cancer	0.0058	0.0058	CcSEcCtD
Dimercaprol—Paraesthesia—Gemcitabine—pancreatic cancer	0.00578	0.00578	CcSEcCtD
Dimercaprol—Asthenia—Sunitinib—pancreatic cancer	0.00575	0.00575	CcSEcCtD
Dimercaprol—Paraesthesia—Fluorouracil—pancreatic cancer	0.00568	0.00568	CcSEcCtD
Dimercaprol—Pain—Irinotecan—pancreatic cancer	0.00565	0.00565	CcSEcCtD
Dimercaprol—Nasopharyngitis—Epirubicin—pancreatic cancer	0.0056	0.0056	CcSEcCtD
Dimercaprol—Nausea—Tamoxifen—pancreatic cancer	0.00556	0.00556	CcSEcCtD
Dimercaprol—Pain—Gemcitabine—pancreatic cancer	0.0055	0.0055	CcSEcCtD
Dimercaprol—Nausea—Erlotinib—pancreatic cancer	0.0055	0.0055	CcSEcCtD
Dimercaprol—Pain—Fluorouracil—pancreatic cancer	0.00541	0.00541	CcSEcCtD
Dimercaprol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.0054	0.0054	CcSEcCtD
Dimercaprol—Muscle spasms—Docetaxel—pancreatic cancer	0.00538	0.00538	CcSEcCtD
Dimercaprol—Abdominal pain—Irinotecan—pancreatic cancer	0.00522	0.00522	CcSEcCtD
Dimercaprol—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.00518	0.00518	CcSEcCtD
Dimercaprol—Vomiting—Sunitinib—pancreatic cancer	0.0051	0.0051	CcSEcCtD
Dimercaprol—Headache—Sunitinib—pancreatic cancer	0.00502	0.00502	CcSEcCtD
Dimercaprol—Nausea—Sunitinib—pancreatic cancer	0.00476	0.00476	CcSEcCtD
Dimercaprol—Asthenia—Irinotecan—pancreatic cancer	0.00474	0.00474	CcSEcCtD
Dimercaprol—Conjunctivitis—Epirubicin—pancreatic cancer	0.00469	0.00469	CcSEcCtD
Dimercaprol—Sweating—Epirubicin—pancreatic cancer	0.00463	0.00463	CcSEcCtD
Dimercaprol—Asthenia—Gemcitabine—pancreatic cancer	0.00462	0.00462	CcSEcCtD
Dimercaprol—Tachycardia—Docetaxel—pancreatic cancer	0.00446	0.00446	CcSEcCtD
Dimercaprol—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00434	0.00434	CcSEcCtD
Dimercaprol—Sweating—Doxorubicin—pancreatic cancer	0.00428	0.00428	CcSEcCtD
Dimercaprol—Vomiting—Irinotecan—pancreatic cancer	0.0042	0.0042	CcSEcCtD
Dimercaprol—Headache—Irinotecan—pancreatic cancer	0.00414	0.00414	CcSEcCtD
Dimercaprol—Paraesthesia—Docetaxel—pancreatic cancer	0.0041	0.0041	CcSEcCtD
Dimercaprol—Vomiting—Gemcitabine—pancreatic cancer	0.00409	0.00409	CcSEcCtD
Dimercaprol—Headache—Gemcitabine—pancreatic cancer	0.00403	0.00403	CcSEcCtD
Dimercaprol—Vomiting—Fluorouracil—pancreatic cancer	0.00402	0.00402	CcSEcCtD
Dimercaprol—Headache—Fluorouracil—pancreatic cancer	0.00396	0.00396	CcSEcCtD
Dimercaprol—Nausea—Irinotecan—pancreatic cancer	0.00392	0.00392	CcSEcCtD
Dimercaprol—Pain—Docetaxel—pancreatic cancer	0.0039	0.0039	CcSEcCtD
Dimercaprol—Nausea—Gemcitabine—pancreatic cancer	0.00382	0.00382	CcSEcCtD
Dimercaprol—Nausea—Fluorouracil—pancreatic cancer	0.00376	0.00376	CcSEcCtD
Dimercaprol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00373	0.00373	CcSEcCtD
Dimercaprol—Muscle spasms—Epirubicin—pancreatic cancer	0.00363	0.00363	CcSEcCtD
Dimercaprol—Abdominal pain—Docetaxel—pancreatic cancer	0.00361	0.00361	CcSEcCtD
Dimercaprol—Agitation—Epirubicin—pancreatic cancer	0.00347	0.00347	CcSEcCtD
Dimercaprol—Muscle spasms—Doxorubicin—pancreatic cancer	0.00336	0.00336	CcSEcCtD
Dimercaprol—Asthenia—Docetaxel—pancreatic cancer	0.00328	0.00328	CcSEcCtD
Dimercaprol—Agitation—Doxorubicin—pancreatic cancer	0.00321	0.00321	CcSEcCtD
Dimercaprol—Anxiety—Epirubicin—pancreatic cancer	0.0032	0.0032	CcSEcCtD
Dimercaprol—Tachycardia—Epirubicin—pancreatic cancer	0.00301	0.00301	CcSEcCtD
Dimercaprol—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00298	0.00298	CcSEcCtD
Dimercaprol—Anxiety—Doxorubicin—pancreatic cancer	0.00296	0.00296	CcSEcCtD
Dimercaprol—Vomiting—Docetaxel—pancreatic cancer	0.0029	0.0029	CcSEcCtD
Dimercaprol—Headache—Docetaxel—pancreatic cancer	0.00286	0.00286	CcSEcCtD
Dimercaprol—Tachycardia—Doxorubicin—pancreatic cancer	0.00278	0.00278	CcSEcCtD
Dimercaprol—Paraesthesia—Epirubicin—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Dimercaprol—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00275	0.00275	CcSEcCtD
Dimercaprol—Nausea—Docetaxel—pancreatic cancer	0.00271	0.00271	CcSEcCtD
Dimercaprol—Pain—Epirubicin—pancreatic cancer	0.00263	0.00263	CcSEcCtD
Dimercaprol—Paraesthesia—Doxorubicin—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Dimercaprol—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Dimercaprol—Pain—Doxorubicin—pancreatic cancer	0.00244	0.00244	CcSEcCtD
Dimercaprol—Abdominal pain—Epirubicin—pancreatic cancer	0.00243	0.00243	CcSEcCtD
Dimercaprol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Dimercaprol—Abdominal pain—Doxorubicin—pancreatic cancer	0.00225	0.00225	CcSEcCtD
Dimercaprol—Asthenia—Epirubicin—pancreatic cancer	0.00221	0.00221	CcSEcCtD
Dimercaprol—Asthenia—Doxorubicin—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Dimercaprol—Vomiting—Epirubicin—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Dimercaprol—Headache—Epirubicin—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Dimercaprol—Nausea—Epirubicin—pancreatic cancer	0.00183	0.00183	CcSEcCtD
Dimercaprol—Vomiting—Doxorubicin—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Dimercaprol—Headache—Doxorubicin—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Dimercaprol—Nausea—Doxorubicin—pancreatic cancer	0.00169	0.00169	CcSEcCtD
